Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia

Psychiatry Research

Volumn 216, Issue 1, 2014, Pages 1-5

  Torgalsbøen, Anne Kari ^a   Mohn, Christine ^b   Rishovd Rund, Bjørn ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

Cognition; Functional outcome; Longitudinal; Psychosis; Recovery

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; FEMALE; HUMAN; INTERVIEW; LEARNING; LONGITUDINAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL COGNITION; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; WORKING MEMORY; CASE CONTROL STUDY; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; ROLE PLAYING; SHORT TERM MEMORY; SOCIAL BEHAVIOR; YOUNG ADULT;

ATTENTION; CASE-CONTROL STUDIES; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; ROLE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 84895894183     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.01.031     Document Type: Article

References (35)

1. Allott K., Liu P., Proffitt T.M., Killackey E. Cognition at illness onset as a predictor of later functional outcome in early psychosis: systematic review and methodological critique. Schizophrenia Research 2011, 125(2-3):221-235.
2. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. revised. Washington.
3. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005, 162:441-449.
4. Cornblatt B.A., Auther A.M., Niendam T., Smith C.W., Zinberg J., Bearden C.E., Cannon T.D. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophrenia Bulletin 2007, 33(3):688-702.
5. Dickerson F.B., Stallings C., Origoni A., Boronow J.J., Sullens A., Yolken R. Predictors of occupational status six months after hospitalization in persons with a recent onset of psychosis. Psychiatry Research 2008, 160(3):278-284.
6. Gold J.M. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research 2004, 72(1):21-28.
7. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996, 153(3):321-330.
8. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophrenia Bulletin 2000, 26(1):119-136.
9. Green M.F., Nuechterlein K.H. Should schizophrenia be treated as a neurocognitive disorder?. Schizophrenia Bulletin 1999, 25(2):309-319.
10. Harding C.M., Brooks G.W., Ashikaga T., Strauss J., Breier A. The Vermont longitudinal study of persons with severe mental illness II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 1987, 144:727-735.
11. Harding C.M. Changes in schizophrenia across time: paradoxes, patterns and predictors. Schizophrenia into Later Life. Treatment Research and Policy 2003, 19-42. APP Press, Washington, DC. C. Cohen (Ed.).
12. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., Dube K.C., Ganev K., Giel R., an der Heiden W., Holmberg S.K., Janca A., Lee P.W.H., Leon C.A., Malhotra S., Marsella A.J., Nakane Y., Sartorius S.N., Shen Y., Skoda C., Thara R., Tsirkin S.J., Varma V.K., Walsh D., Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry 2001, 178(6):506-517.
13. Harrow M., Grossman L.S., Jobe T.H., Herbener E.S. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophrenia Bulletin 2005, 31(3):723-734.
14. Harrow M., Jobe T.H. Factors Involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. Journal of Nervous and Mental Disease 2007, 195(5):406-414.
15. Harvey P.D., Bellack A.S. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?. Schizophrenia Bulletin 2009, 35:300-306.
16. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. Journal of Psychiatric Research 2006, 40(8):738-745.
17. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophrenia Research 2007, 93(1-3):160-168.
18. Hert M.D., van Winkel R., Wampers M., Kane J., van Os J., Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophrenia Research 2007, 2(1-3):68-73.
19. Holthausen E.A.E., Wiersma D., Cahn W., Kahn R.S., Dingemans P.M., Schene A.H., van den Bosch R.J. Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Research 2007, 149(1-3):71-80.
20. Holmén A., Juuhl-Langseth M., Thormodsen R., Melle I., Rund B.R. Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery. Schizophrenia Bulletin 2009, 36(4):852-859.
21. Kay S.R., Fiszbein A., Opfer L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13(2):261-276.
22. Keefe R.S, Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Capuano G., Stroup T.S., McEvoy J.P., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the catie trial. Archives of General Psychiatry 2007, 64(6):633-647.
23. Lambert M., Karow A., Leucht S., Schimmelmann B.G., Naber D. Remission in schizophrenia: validity, frequency, predictors and patients[U+05F3] perspective 5 years later. Dialogues in Clinical Neuroscience 2010, 12(3):393-407.
24. Marshall, M., Rathbone, J., 2011. Early intervention for psychosis. Cochrane Database of Systematic Reviews, Issue 6, Art. No.: CD004718. http://dx.doi.org/10.1002/14651858.CD004718.pub3.
25. Mesholam-Gately R.I., Giuliano A.J., Goff K.P., Faraone S.V., Seidman L.J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23(3):315-336.
26. Mohn C., Sundet K., Rund B.R. The Norwegian standardization of the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) consensus cognitive battery. Journal of Clinical and Experimental Neuropsychology 2012, 34(6):667-677.
27. Nuechterlein K.H., Green M.F. MATRICS consensus cognitive battery. Manual 2006, MATRICS Assessment Inc, Los Angeles, CA.
28. Nuechterlein K.H., Green M.F. MATRICS Consensus Cognitive Battery, Norwegian Version (B.R. Rund & K.S. Sundet, Trans.) 2009, MATRICS Assessment Inc, Los Angeles, CA.
29. Oorschot M., Lataster T., Thewissen V., Lardinois M., van Os J., Delespaul P.A.E.G., Myin-Germeys I. Symptomatic remission in psychosis and real-life functioning. British Journal of Psychiatry 2012, 201(3):215-220.
30. Rund B.R., Melle I., Friis S., Larsen T.K., Midbøe L.J., Opjordsmoen S., Simonsen E., Vaglum P., McGlashan T. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. American Journal of Psychiatry 2004, 161:466-472.
31. Rund B.R., Melle I., Friis S., Johannessen J.O., Larsen T.K., Midbøe L.J., Opjordsmoen S., Simonsen E., Vaglum P., McGlashan T. The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophrenia Research 2007, 91(1-3):132-140.
32. Simonsen E., Friis S., Haahr U., Johannessen J.O., Larsen T.K., Melle I., Opjordsmoen S., Rund B.R., Vaglum P., McGlashan T. Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatrica Scandinavica 2007, 116(1):54-61.
33. Ventura J., Subotnik K.L., Guzik L.H., Hellemann G.S., Gitlin M.J., Wood R.C., Nuechterlein K.H. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophrenia Research 2011, 132(1):18-23.
34. Verdoux H., Liraud F., Assens F., van Os J. Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophrenia Research 2002, 56(1-2):148-159.
35. WHO, 2010. Collaborating Centre for Drug statistics Methodology. DDD-Definitions and General Considerations. www.whocc.no. n. http://www.whocc.no/atc_ddd_index/?code=N05AH&showdescription=yes.